/Investor DB

Ben Franklin Technology Partners — 2025 Investments

6 investments dated 2025 · listed companies and verified rows first · show all

Blind Tigerblindtigerspiritfree.com𝕏May 2025

Blind Tiger Spirit Free is a beverage company that produces non-alcoholic spirits and mocktails, including flavored sparkling drinks like the Southside Mojito made with real ingredients.

ConsumerDirect to ConsumerFoodTechWellness & FitnessErie, US

Brett Rehorn(Executive Officer, Director, Promoter)Rebecca Styn(Founder)in

Co-investorsBoston Harbor AngelsExpert DOJO

Moberg Analyticsmoberganalytics.comin𝕏Oct 2025

Moberg Analytics develops the Moberg Clinical Platform (MCP), software that aggregates and analyzes high-resolution multimodal neuromonitoring data from disparate ICU devices into near real-time insights.

AI & Machine LearningBiotechDigital HealthMedical DevicesPhiladelphia, US

Dick Moberg(Founder & CEO)

Co-investorsMVP

Mosqittermosqitter.comin𝕏Dec 2025

Mosqitter manufactures chemical-free mosquito control devices that use heat, UV light, and CO2 to attract and trap mosquitoes, offering both compact indoor/outdoor and premium outdoor solutions for residential and commercial properties.

CleantechWellness & FitnessEast Stroudsburg, US

Olga Diachuk(Founder)in

Co-investorsAngel OneTechstars

Mussel Polymersmusselpolymers.comDec 2025

Mussel Polymers develops bio-inspired adhesive solutions based on mussel-derived chemistry for underwater, high-moisture, and specialized industrial applications including medical, military, and marine restoration.

Advanced ManufacturingBiotechDeep TechNew MaterialsBethlehem, US

George Boyajian(Chief Executive Officer)inJon Wilker(Lead Scientist)

BoardKevin Ohashi(Director)Eric Anderson(Director)

Co-investorsNW AngelWealthing VC ClubBen Franklin Technology Partners of Northeastern PennsylvaniaSoftBank Group

SFA Therapeuticssfatherapeutics.comin𝕏Seed · Apr 2025

SFA Therapeutics develops oral therapeutic candidates based on deuterated short-chain fatty acids to treat autoimmune and oncologic diseases.

BiotechHealthtechPhiladelphia, US

Ira Spector(Founder)inAlla Arzumanyan(Founder)inMark Feitelson(Founder)in

Co-investorsAcequia Capital (AceCap)Farvatn VentureImmeasurableINP CapitalNorth South VenturesPlanet 9 Capital+7 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

FLX Solutions

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.